In today’s Pharmaceutical Executive Daily, we cover Lilly’s orforglipron as a prime candidate for FDA fast-track approval, Merck and Daiichi Sankyo’s breakthrough therapy designation for R-DXd in ovarian cancer, and Novo Nordisk’s EU approval of Rybelsus for reducing cardiovascular risk.

هنتكلم انهاردة عن ظاهرة غريبة أثارت الرأي العام و استغراب ناس كتير يلا بينا نبدأ 😉

This episode explores the mysterious phenomenon of dream déjà vu—the sense of reliving a dream or experiencing something in waking life that feels like it already happened in a dream. Science explains it as a memory glitch, where feelings of familiarity are triggered without full recollection, or as the brain recycling and reshaping memories during sleep.Dream déjà vu may also reflect emotional themes that repeat in the unconscious, much like recurring dreams. While cultural and spiritual

Dr. Russell Sharp examines the severe crop losses in Latvia caused by heavy spring and late-season rainfall, flooding and seed washout that destroyed vegetables like onions, carrots, cabbages and potatoes. He explains how these conditions have left farmers facing large economic losses and likely increased imports and prices. The episode contrasts Latvia’s wet, unstable “climate frontline” with the UK’s recent drought conditions, touches on Estonia’s high organic output, and asks listeners for

This week’s tHEORetically Speaking News Roundup covers new research on social-genetic influences in adolescent depression, Novartis’s $1.4B acquisition of Tourmaline Bio for a promising heart drug, and encouraging Phase 2 results for rezatapopt in solid tumors. We also explore the FDA’s draft guidance on non-opioid pain treatments and the AMA’s release of 2026 CPT codes amid growing scrutiny. Tune in for this concise recap of these pivotal industry updates!

In this episode, we remind ourselves - it's my body and my choice.[0.01] Introduction[0.43] Chelle reads the storybook[1.10] Evie guides listeners through the tool Tap It Out[3.08] Outro This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit michellemcquaid.substack.com

This episode explores the challenges of surviving in extreme cold and snowy conditions. It highlights the life-threatening risks of hypothermia and frostbite, explaining early warning signs and prevention methods such as layering clothing, staying dry, and protecting extremities. Shelter is emphasized as a critical factor, with options ranging from snow caves to makeshift windbreaks that trap body heat.The episode also underscores the importance of hydration, warning against eating snow directly

Today's episode covers the president’s call to lower drug costs for patients, the compliance and operational pressures facing pharmaceutical manufacturers, and a White House plan to restrict treatments discovered in China.

Start your day with positivity and peace. This episode brings you powerful inspiration good morning blessings quotes to uplift your spirit, boost your mood, and help you welcome the day with gratitude and joy.

Telehealth and pharma are facing some of their biggest compliance challenges yet—and the latest enforcement actions prove regulators aren’t slowing down. On one side, the FTC is investigating Hims & Hers, a popular telehealth company, over allegations of misleading advertising and unfair cancellation practices. This case highlights how patient-facing companies must tread carefully when making claims about access, outcomes, or subscription services. The FTC’s involvement signals that “grow...

In today’s Pharmaceutical Executive Daily, we cover Lundbeck’s restructuring affecting more than 600 international employees, Novo Nordisk’s global plan to cut 9,000 jobs, and former President Trump’s push to rein in pharmaceutical direct-to-consumer advertising.